WM-8014 is primarily used in research settings as a selective inhibitor of histone deacetylase 6 (HDAC6). Its application lies in the study of epigenetic regulation and cellular processes such as protein degradation, cell motility, and immune response. Due to its specificity for HDAC6, it is a valuable tool in investigating diseases where HDAC6 activity is implicated, including certain cancers, neurodegenerative disorders like Alzheimer’s disease, and inflammatory conditions. WM-8014 helps researchers dissect the role of HDAC6 without broadly affecting other HDAC enzymes, making it useful for developing targeted therapies. It is not used clinically but supports preclinical studies aimed at understanding disease mechanisms and evaluating potential treatment strategies.